| Dr Karen Lynn Furlong, PHARMD | |
|
1983 S Main St, Lebanon, OR 97355-3142 | |
| (541) 259-5706 | |
| Not Available |
| Full Name | Dr Karen Lynn Furlong |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1983 S Main St, Lebanon, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356825111 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PI-0011715 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen Lynn Furlong, PHARMD 1983 S Main St, Lebanon, OR 97355-3142 Ph: (541) 259-5706 | Dr Karen Lynn Furlong, PHARMD 1983 S Main St, Lebanon, OR 97355-3142 Ph: (541) 259-5706 |
News Archive
The U.S. Food and Drug Administration today approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke—a stroke caused by a blockage of blood flow to the brain with long-lasting symptoms—using vagus nerve stimulation (VNS).
The creation of a successful vaccine against cervical cancer, approved today by the U.S. Food and Drug Administration, is the culmination of research that occurred thanks not only to scientists and physicians, but also to generous farmers and veterinarians, priests and nuns willing to tell all - and some very patient cows.
Barclay Morrison III, associate professor of biomedical engineering at Columbia Engineering, has led the first study to determine underlying biological mechanisms that promote functional recovery of the blood-brain barrier (BBB) after blast injury. The research demonstrates that treatment with the glucocorticoid, dexamethasone, after primary blast injury promotes rapid recovery of an in vitro model of the BBB, a highly restrictive semi-permeable barrier whose primary function is to maintain the brain's microenvironment and protect it from potentially toxic substances.
Patient care at St. Jude doesn't stop when the child is cured. The end of successful therapy is the start of many years of follow-up care. This care is aimed at helping make the recovery process successful and preparing the family and hometown doctor for long-term complications that might arise from the disease or its treatment.
Researchers have found that mice fed a palatable high-fat diet experience stress responses that resemble drug withdrawal when their food is switched to a low-fat diet.
› Verified 4 days ago
Hong Ngoc Nguyen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 675 N Fifth Street, Lebanon, OR 97355 Phone: 541-451-7119 Fax: 541-451-7072 | |
Janie Louise Thomas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 185 S Main St, Lebanon, OR 97355 Phone: 541-259-1225 | |
Mrs. Karen Ann Johnston, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 675 N 5th St, Lebanon, OR 97355 Phone: 541-451-7119 Fax: 541-451-7072 | |
Heidi Ann Glen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 N Santiam Hwy, Lebanon, OR 97355 Phone: 541-451-7565 | |
Whitney Macnab, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3290 S Santiam Hwy, Lebanon, OR 97355 Phone: 541-258-7440 | |
Mr. David Phillip Redden, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Burdell Blvd, Lebanon, OR 97355 Phone: 541-451-3502 Fax: 541-451-3508 | |
Juliet Oneal Strahl, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Burdell Blvd, Lebanon, OR 97355 Phone: 541-451-3502 |